Samarth Kulkarni

Companies

• Oruka Therapeutics, Inc.Board member Sep 6, 2024 to now¹
• Centessa Pharmaceuticals plcBoard member May 27, 2021 to now²
• Black Diamond Therapeutics, Inc.Board member Jan 29, 2020 to now³
• CRISPR TherapeuticsBoard member Jun 5, 2018 to now⁴
• CRISPR TherapeuticsChief executive officer Dec 5, 2017 to now⁵
• Repare Therapeutics Inc.Board member Jun 18, 2020 to Jun 20, 2024⁶
• CRISPR TherapeuticsChief Business Officer Oct 18, 2016 to Aug 30, 2017⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CRISPR Therapeutics CRSP341,123 shares⁸$16.8M at $49.25Mar 23, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 23, 2026Sold 10,020 shares at $46.78 of CRISPR Therapeutics⁸
• Mar 20, 2026Exercised options 19,687 shares of CRISPR Therapeutics⁸
• Mar 16, 2026Sold 10,349 shares at $48.26 of CRISPR Therapeutics⁹
• Mar 14, 2026Exercised options 20,625 shares of CRISPR Therapeutics⁹
• Mar 11, 2026Sold 9,798 shares at $52.80 of CRISPR Therapeutics¹⁰
• Mar 10, 2026Exercised options 19,250 shares of CRISPR Therapeutics¹⁰
• Feb 19, 2026Sold 6,967 shares at $52.58 of CRISPR Therapeutics¹¹
• Feb 18, 2026Exercised options 13,250 shares of CRISPR Therapeutics¹¹
• Jan 22, 2026Sold 60,000 shares at $60.23 of CRISPR Therapeutics¹²
• Jan 20, 2026Sold 8,567 shares at $52.10 of CRISPR Therapeutics¹²
• Jan 20, 2026Sold 21,433 shares at $51.61 of CRISPR Therapeutics¹²
• Dec 18, 2025Gift 30,000 shares of CRISPR Therapeutics¹³
• Oct 17, 2025Sold 50,895 shares at $67.91 of CRISPR Therapeutics¹⁴
• Oct 16, 2025Exercised options 100,000 shares of CRISPR Therapeutics¹⁴
• Oct 14, 2025Sold 4,242 shares at $66.60 of CRISPR Therapeutics¹⁵
• Oct 13, 2025Exercised options 8,334 shares of CRISPR Therapeutics¹⁵
• Sep 17, 2025Gift 6,000 shares of CRISPR Therapeutics¹⁶
• Aug 18, 2025Sold 13,081 shares at $58.15 of CRISPR Therapeutics¹⁷
• Aug 16, 2025Exercised options 25,000 shares of CRISPR Therapeutics¹⁷
• Mar 21, 2025Sold 10,031 shares at $41.23 of CRISPR Therapeutics¹⁸
• Mar 20, 2025Exercised options 19,688 shares of CRISPR Therapeutics¹⁸
• Mar 12, 2025Sold 4,462 shares at $43.32 of CRISPR Therapeutics¹⁹
• Mar 11, 2025Exercised options 9,000 shares of CRISPR Therapeutics¹⁹
• Mar 11, 2025Sold 9,973 shares at $42.42 of CRISPR Therapeutics¹⁹
• Mar 10, 2025Exercised options 19,250 shares of CRISPR Therapeutics¹⁹